Our Approach
How to understand the true impact of a chronic condition on everyday life
Development of European payer value stories and communication tools for two products treating a rare bleeding disorder
Value Communications
Development of European payer value stories and communication tools for two products treating a rare bleeding disorder
A global biotech client needed to develop an EU payer value story and communication tool for two products indicated for the treatment of rare bleeding disorder.
Global HTA & payer landscape assessment for metabolic indication
Evidence, Pricing, and Access Strategy
Global HTA & payer landscape assessment for metabolic indication
Our client was the Senior Director of Global Market Access and Pricing of a global mid-size pharmaceutical company who recently acquired a new asset for a metabolic indication. They wanted to explore evidence gaps in the development plan on potential mitigation strategies to optimise price and access outcomes in France, Germany, Italy, Spain, the UK, Nordics, Switzerland, Australia, Canada, China and South Korea.
Assessment of Future Payer Environment for Pipeline Products using a Payer Advisory Board
Payer Environment Assessment
Assessment of Future Payer Environment for Pipeline Products using a Payer Advisory Board
Our client, the global pricing and market access function of a specialist biopharmaceutical orphan drug company, wanted to hold a payer advisory board to review its entire pipeline.
Programme of negotiation training to support pricing and market access objectives for legacy products
Payer Negotiation Training
Programme of negotiation training to support pricing and market access objectives for legacy products
A major multinational pharma client wanted to prepare for ongoing and future payer engagements for three high-priority legacy products across multiple markets in Europe and Latin America.